For payers and organizations committed to delivering the best possible care for patients while controlling costs, the pharmacy landscape has a high degree of financial risk. New drugs are approved faster than ever, even while evidence of efficacy continues to evolve.
Advanced research increasingly results in highly specialized – yet often costly – treatments for particular conditions and patient populations. Simultaneously, price doesn’t always reflect a new drug’s clinical impact, and value-oriented payment strategies continue to shift.
We can help you make sense of this complex landscape through budget impact forecasting – a comprehensive clinical and financial assessment of the drug pipeline. To produce curated and customized data-driven insights, our clinical pharmacists employ:
- Pipeline monitoring
- Evidence-based medicine review
- Market intelligence
- Pharmacy & medical claims analysis
Our independent and transparent forecasts arm you with the intelligence needed to support proactive contract negotiations and implement proactive formulary management strategies.